CN Stock MarketDetailed Quotes

688336 Sunshine Guojian Pharmaceutical

Watchlist
  • 18.20
  • +0.50+2.82%
Market Closed Sep 13 15:00 CST
11.23BMarket Cap34.08P/E (TTM)

Sunshine Guojian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
24.87%596.62M
28.72%266.9M
22.84%1.01B
38.54%730.6M
40.28%477.81M
29.17%207.34M
-11.12%825.49M
-16.03%527.35M
-28.85%340.6M
3.34%160.51M
Operating revenue
24.87%596.62M
28.72%266.9M
22.84%1.01B
38.54%730.6M
40.28%477.81M
29.17%207.34M
-11.12%825.49M
-16.03%527.35M
-28.85%340.6M
3.34%160.51M
Total operating cost
13.40%448.87M
-5.73%169.63M
-4.84%791.66M
-0.93%573.32M
2.99%395.82M
2.49%179.93M
-17.91%831.92M
-18.19%578.72M
-24.60%384.34M
-18.74%175.56M
Operating cost
33.56%159.11M
7.21%61.18M
11.38%224.1M
23.57%168.23M
36.38%119.13M
39.14%57.07M
-4.20%201.2M
0.12%136.14M
-12.65%87.35M
53.05%41.01M
Operating tax surcharges
0.04%4.6M
11.02%2.14M
50.47%9.37M
83.25%6.84M
55.00%4.6M
-1.93%1.93M
51.53%6.23M
64.05%3.73M
75.77%2.96M
237.77%1.97M
Operating expense
4.51%131.87M
-4.05%51.39M
0.54%251.79M
10.45%194.87M
7.03%126.18M
5.64%53.55M
-5.59%250.45M
-7.47%176.43M
-23.18%117.89M
-34.52%50.7M
Administration expense
0.77%34.85M
17.97%16.92M
-23.72%63.1M
-21.24%52.13M
-22.76%34.58M
-40.63%14.34M
-18.79%82.73M
-15.23%66.18M
-14.30%44.77M
9.25%24.16M
Financial expense
-58.96%-29.21M
-114.85%-15.17M
-77.56%-39.01M
-39.57%-28.39M
-20.89%-18.38M
-9.66%-7.06M
4.34%-21.97M
-16.94%-20.34M
-31.43%-15.2M
11.42%-6.44M
-Interest expense (Financial expense)
-22.32%608.1K
-39.23%302.8K
6.54%1.4M
146.81%1.1M
--782.8K
--498.3K
--1.32M
--444.03K
----
----
-Interest Income (Financial expense)
-75.25%-29.55M
-85.03%-14.94M
-98.16%-39.64M
-62.52%-27.76M
-34.34%-16.86M
-25.96%-8.08M
16.44%-20M
0.26%-17.08M
-8.56%-12.55M
-2.52%-6.41M
Research and development
13.83%147.65M
-11.55%53.16M
-9.89%282.3M
-17.05%179.65M
-11.50%129.71M
-6.33%60.1M
-31.16%313.28M
-31.85%216.58M
-31.48%146.56M
-33.44%64.16M
Credit Impairment Loss
-101.55%-103K
-347.08%-389.9K
223.83%6.8M
213.52%6.82M
209.10%6.63M
-68.58%157.8K
-345.19%-5.49M
-455.81%-6M
-164.17%-6.08M
-7.84%502.31K
Asset Impairment Loss
76.39%-93.5K
-105.45%-72K
129.44%1.06M
88.04%-456.26K
90.54%-396.1K
253.70%1.32M
---3.61M
---3.81M
---4.19M
---860.14K
Other net revenue
Fair value change income
-47.02%5.11M
11.33%5.41M
-45.29%19.4M
-44.75%13.74M
-30.10%9.65M
-15.03%4.86M
46.49%35.46M
33.55%24.88M
12.31%13.81M
-12.33%5.72M
Invest income
-55.26%-13.27M
8.30%-3.44M
-5.93%-16.4M
-33,929.59%-12.81M
-22,590.71%-8.54M
---3.75M
-372.27%-15.48M
-101.83%-37.66K
-101.83%-37.66K
----
-Including: Investment income associates
-55.26%-13.27M
8.30%-3.44M
-5.93%-16.4M
-33,929.59%-12.81M
-22,590.71%-8.54M
---3.75M
-372.27%-15.48M
-101.83%-37.66K
-101.83%-37.66K
----
Asset deal income
93.95%-83.5K
----
6,068.23%56.39M
-81.84%-1.42M
-828.90%-1.38M
-157.39%-333.9K
92.72%-944.86K
28.19%-782.4K
70.82%-148.55K
72.11%-129.73K
Other revenue
42.10%10.33M
55.17%5.09M
-14.55%28.58M
-48.76%11.27M
-58.37%7.27M
-29.59%3.28M
-2.37%33.45M
34.17%22M
58.41%17.46M
-15.35%4.66M
Operating profit
57.16%149.65M
215.32%103.87M
761.35%318.21M
1,253.09%174.42M
515.53%95.22M
738.37%32.94M
184.68%36.94M
65.99%-15.13M
-172.02%-22.92M
89.59%-5.16M
Less:Non operating expense
559.92%11.26M
200.04%4M
-5.11%7.58M
-2.93%5.16M
-51.18%1.71M
-43.66%1.33M
-18.13%7.99M
13.96%5.32M
2.89%3.5M
-10.05%2.37M
Total profit
47.98%138.39M
215.96%99.87M
972.79%310.63M
927.95%169.26M
454.06%93.52M
519.92%31.61M
154.24%28.96M
58.40%-20.44M
-123.40%-26.41M
85.58%-7.53M
Less:Income tax cost
221.53%14.02M
988.64%11.11M
265.51%27.27M
199.39%14.36M
132.75%4.36M
120.70%1.02M
68.12%-16.48M
62.56%-14.45M
43.97%-13.31M
69.45%-4.93M
Net profit
39.49%124.37M
190.20%88.76M
523.67%283.36M
FLtoP154.9M
FLtoP89.16M
FLtoP30.59M
FLtoP45.43M
FPtoL-6M
SL-13.1M
FPtoL-2.6M
Net profit from continuing operation
39.49%124.37M
190.20%88.76M
523.67%283.36M
2,683.45%154.9M
780.47%89.16M
1,277.08%30.59M
2,778.75%45.43M
43.17%-6M
-209.79%-13.1M
92.79%-2.6M
Less:Minority Profit
8.14%-5.14M
19.47%-2.36M
-191.35%-11.25M
-25.69%-9.02M
5.34%-5.6M
0.67%-2.93M
80.45%-3.86M
55.90%-7.17M
43.63%-5.91M
37.63%-2.95M
Net profit of parent company owners
36.68%129.51M
171.88%91.12M
497.63%294.61M
13,826.23%163.92M
1,417.98%94.75M
9,494.38%33.51M
172.99%49.3M
-79.40%1.18M
-132.06%-7.19M
101.12%349.32K
Earning per share
Basic earning per share
40.00%0.21
200.00%0.15
500.00%0.48
--0.27
1,600.00%0.15
--0.05
166.67%0.08
--0
-125.00%-0.01
--0
Diluted earning per share
40.00%0.21
200.00%0.15
500.00%0.48
--0.27
1,600.00%0.15
--0.05
166.67%0.08
--0
-125.00%-0.01
--0
Other composite income
-149.44%-2.54M
127.94%930K
-70.63%1.96M
-67.18%4.55M
14.67%5.14M
29.60%-3.33M
187.11%6.66M
855.82%13.86M
259.76%4.48M
-824.94%-4.73M
Other composite income of parent company owners
-149.44%-2.54M
127.94%930K
-70.63%1.96M
-67.18%4.55M
14.67%5.14M
29.60%-3.33M
187.11%6.66M
855.82%13.86M
259.76%4.48M
-824.94%-4.73M
Add:Adjusted items effecting composite income
----
--100
----
----
----
----
----
----
----
----
Total composite income
29.20%121.83M
229.05%89.69M
447.69%285.32M
1,928.67%159.45M
1,193.50%94.29M
472.02%27.26M
657.63%52.09M
186.36%7.86M
-165.43%-8.62M
79.30%-7.33M
Total composite income of parent company owners
27.11%126.97M
204.94%92.05M
429.99%296.57M
1,020.65%168.46M
3,785.79%99.89M
789.32%30.19M
437.41%55.96M
109.82%15.03M
-111.45%-2.71M
85.72%-4.38M
Total composite income of minority owners
8.14%-5.14M
19.47%-2.36M
-191.35%-11.25M
-25.69%-9.02M
5.34%-5.6M
0.67%-2.93M
80.45%-3.86M
55.90%-7.17M
43.63%-5.91M
37.63%-2.95M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
--
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 24.87%596.62M28.72%266.9M22.84%1.01B38.54%730.6M40.28%477.81M29.17%207.34M-11.12%825.49M-16.03%527.35M-28.85%340.6M3.34%160.51M
Operating revenue 24.87%596.62M28.72%266.9M22.84%1.01B38.54%730.6M40.28%477.81M29.17%207.34M-11.12%825.49M-16.03%527.35M-28.85%340.6M3.34%160.51M
Total operating cost 13.40%448.87M-5.73%169.63M-4.84%791.66M-0.93%573.32M2.99%395.82M2.49%179.93M-17.91%831.92M-18.19%578.72M-24.60%384.34M-18.74%175.56M
Operating cost 33.56%159.11M7.21%61.18M11.38%224.1M23.57%168.23M36.38%119.13M39.14%57.07M-4.20%201.2M0.12%136.14M-12.65%87.35M53.05%41.01M
Operating tax surcharges 0.04%4.6M11.02%2.14M50.47%9.37M83.25%6.84M55.00%4.6M-1.93%1.93M51.53%6.23M64.05%3.73M75.77%2.96M237.77%1.97M
Operating expense 4.51%131.87M-4.05%51.39M0.54%251.79M10.45%194.87M7.03%126.18M5.64%53.55M-5.59%250.45M-7.47%176.43M-23.18%117.89M-34.52%50.7M
Administration expense 0.77%34.85M17.97%16.92M-23.72%63.1M-21.24%52.13M-22.76%34.58M-40.63%14.34M-18.79%82.73M-15.23%66.18M-14.30%44.77M9.25%24.16M
Financial expense -58.96%-29.21M-114.85%-15.17M-77.56%-39.01M-39.57%-28.39M-20.89%-18.38M-9.66%-7.06M4.34%-21.97M-16.94%-20.34M-31.43%-15.2M11.42%-6.44M
-Interest expense (Financial expense) -22.32%608.1K-39.23%302.8K6.54%1.4M146.81%1.1M--782.8K--498.3K--1.32M--444.03K--------
-Interest Income (Financial expense) -75.25%-29.55M-85.03%-14.94M-98.16%-39.64M-62.52%-27.76M-34.34%-16.86M-25.96%-8.08M16.44%-20M0.26%-17.08M-8.56%-12.55M-2.52%-6.41M
Research and development 13.83%147.65M-11.55%53.16M-9.89%282.3M-17.05%179.65M-11.50%129.71M-6.33%60.1M-31.16%313.28M-31.85%216.58M-31.48%146.56M-33.44%64.16M
Credit Impairment Loss -101.55%-103K-347.08%-389.9K223.83%6.8M213.52%6.82M209.10%6.63M-68.58%157.8K-345.19%-5.49M-455.81%-6M-164.17%-6.08M-7.84%502.31K
Asset Impairment Loss 76.39%-93.5K-105.45%-72K129.44%1.06M88.04%-456.26K90.54%-396.1K253.70%1.32M---3.61M---3.81M---4.19M---860.14K
Other net revenue
Fair value change income -47.02%5.11M11.33%5.41M-45.29%19.4M-44.75%13.74M-30.10%9.65M-15.03%4.86M46.49%35.46M33.55%24.88M12.31%13.81M-12.33%5.72M
Invest income -55.26%-13.27M8.30%-3.44M-5.93%-16.4M-33,929.59%-12.81M-22,590.71%-8.54M---3.75M-372.27%-15.48M-101.83%-37.66K-101.83%-37.66K----
-Including: Investment income associates -55.26%-13.27M8.30%-3.44M-5.93%-16.4M-33,929.59%-12.81M-22,590.71%-8.54M---3.75M-372.27%-15.48M-101.83%-37.66K-101.83%-37.66K----
Asset deal income 93.95%-83.5K----6,068.23%56.39M-81.84%-1.42M-828.90%-1.38M-157.39%-333.9K92.72%-944.86K28.19%-782.4K70.82%-148.55K72.11%-129.73K
Other revenue 42.10%10.33M55.17%5.09M-14.55%28.58M-48.76%11.27M-58.37%7.27M-29.59%3.28M-2.37%33.45M34.17%22M58.41%17.46M-15.35%4.66M
Operating profit 57.16%149.65M215.32%103.87M761.35%318.21M1,253.09%174.42M515.53%95.22M738.37%32.94M184.68%36.94M65.99%-15.13M-172.02%-22.92M89.59%-5.16M
Less:Non operating expense 559.92%11.26M200.04%4M-5.11%7.58M-2.93%5.16M-51.18%1.71M-43.66%1.33M-18.13%7.99M13.96%5.32M2.89%3.5M-10.05%2.37M
Total profit 47.98%138.39M215.96%99.87M972.79%310.63M927.95%169.26M454.06%93.52M519.92%31.61M154.24%28.96M58.40%-20.44M-123.40%-26.41M85.58%-7.53M
Less:Income tax cost 221.53%14.02M988.64%11.11M265.51%27.27M199.39%14.36M132.75%4.36M120.70%1.02M68.12%-16.48M62.56%-14.45M43.97%-13.31M69.45%-4.93M
Net profit 39.49%124.37M190.20%88.76M523.67%283.36MFLtoP154.9MFLtoP89.16MFLtoP30.59MFLtoP45.43MFPtoL-6MSL-13.1MFPtoL-2.6M
Net profit from continuing operation 39.49%124.37M190.20%88.76M523.67%283.36M2,683.45%154.9M780.47%89.16M1,277.08%30.59M2,778.75%45.43M43.17%-6M-209.79%-13.1M92.79%-2.6M
Less:Minority Profit 8.14%-5.14M19.47%-2.36M-191.35%-11.25M-25.69%-9.02M5.34%-5.6M0.67%-2.93M80.45%-3.86M55.90%-7.17M43.63%-5.91M37.63%-2.95M
Net profit of parent company owners 36.68%129.51M171.88%91.12M497.63%294.61M13,826.23%163.92M1,417.98%94.75M9,494.38%33.51M172.99%49.3M-79.40%1.18M-132.06%-7.19M101.12%349.32K
Earning per share
Basic earning per share 40.00%0.21200.00%0.15500.00%0.48--0.271,600.00%0.15--0.05166.67%0.08--0-125.00%-0.01--0
Diluted earning per share 40.00%0.21200.00%0.15500.00%0.48--0.271,600.00%0.15--0.05166.67%0.08--0-125.00%-0.01--0
Other composite income -149.44%-2.54M127.94%930K-70.63%1.96M-67.18%4.55M14.67%5.14M29.60%-3.33M187.11%6.66M855.82%13.86M259.76%4.48M-824.94%-4.73M
Other composite income of parent company owners -149.44%-2.54M127.94%930K-70.63%1.96M-67.18%4.55M14.67%5.14M29.60%-3.33M187.11%6.66M855.82%13.86M259.76%4.48M-824.94%-4.73M
Add:Adjusted items effecting composite income ------100--------------------------------
Total composite income 29.20%121.83M229.05%89.69M447.69%285.32M1,928.67%159.45M1,193.50%94.29M472.02%27.26M657.63%52.09M186.36%7.86M-165.43%-8.62M79.30%-7.33M
Total composite income of parent company owners 27.11%126.97M204.94%92.05M429.99%296.57M1,020.65%168.46M3,785.79%99.89M789.32%30.19M437.41%55.96M109.82%15.03M-111.45%-2.71M85.72%-4.38M
Total composite income of minority owners 8.14%-5.14M19.47%-2.36M-191.35%-11.25M-25.69%-9.02M5.34%-5.6M0.67%-2.93M80.45%-3.86M55.90%-7.17M43.63%-5.91M37.63%-2.95M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------------Unqualified opinion------
Auditor ------------Ernst & Young (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data